110 related articles for article (PubMed ID: 26402624)
21. Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.
Villarreal S; Zhao F; Hyde LA; Holder D; Forest T; Sondey M; Chen X; Sur C; Parker EM; Kennedy ME
J Alzheimers Dis; 2017; 59(4):1393-1413. PubMed ID: 28800329
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.
Saiz-Sanchez D; Ubeda-Bañon I; De la Rosa-Prieto C; Martinez-Marcos A
J Alzheimers Dis; 2012; 31(1):113-29. PubMed ID: 22543847
[TBL] [Abstract][Full Text] [Related]
23. Peripherally applied synthetic tetrapeptides HAEE and RADD slow down the development of cerebral β-amyloidosis in AβPP/PS1 transgenic mice.
Tsvetkov PO; Cheglakov IB; Ovsepyan AA; Mediannikov OY; Morozov AO; Telegin GB; Kozin SA
J Alzheimers Dis; 2016; 49(1):265. PubMed ID: 26529394
[No Abstract] [Full Text] [Related]
24. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
25. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
[TBL] [Abstract][Full Text] [Related]
27. Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell death.
Lison H; Happel MF; Schneider F; Baldauf K; Kerbstat S; Seelbinder B; Schneeberg J; Zappe M; Goldschmidt J; Budinger E; Schröder UH; Ohl FW; Schilling S; Demuth HU; Scheich H; Reymann KG; Rönicke R
Neurobiol Dis; 2014 Mar; 63():62-73. PubMed ID: 24291517
[TBL] [Abstract][Full Text] [Related]
28. Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice.
Li C; Zug C; Qu H; Schluesener H; Zhang Z
Behav Brain Res; 2015 Mar; 281():32-42. PubMed ID: 25510196
[TBL] [Abstract][Full Text] [Related]
29. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
[TBL] [Abstract][Full Text] [Related]
30. Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.
Bhattacharya S; Maelicke A; Montag D
J Alzheimers Dis; 2015; 46(1):123-36. PubMed ID: 25720404
[TBL] [Abstract][Full Text] [Related]
31. β-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 mice.
Wei G; Chen YB; Chen DF; Lai XP; Liu DH; Deng RD; Zhou JH; Zhang SX; Li YW; Lii H; Liu LF; Wang Q; Nie H
J Alzheimers Dis; 2013; 33(3):863-80. PubMed ID: 23064259
[TBL] [Abstract][Full Text] [Related]
32. Elevation of zinc transporter ZnT3 protein in the cerebellar cortex of the AbetaPP/PS1 transgenic mouse.
Zheng W; Wang T; Yu D; Feng WY; Nie YX; Stoltenberg M; Danscher G; Wang ZY
J Alzheimers Dis; 2010; 20(1):323-31. PubMed ID: 20164588
[TBL] [Abstract][Full Text] [Related]
33. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
[TBL] [Abstract][Full Text] [Related]
34. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
[TBL] [Abstract][Full Text] [Related]
35. Peripheral amyloid levels present gender differences associated with aging in AβPP/PS1 mice.
Ordóñez-Gutiérrez L; Antón M; Wandosell F
J Alzheimers Dis; 2015; 44(4):1063-8. PubMed ID: 25408213
[TBL] [Abstract][Full Text] [Related]
36. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
[TBL] [Abstract][Full Text] [Related]
37. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.
James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ
ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708
[TBL] [Abstract][Full Text] [Related]
38. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
39. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar amyloid-β plaques: disturbed cortical circuitry in AβPP/PS1 transgenic mice as a model of familial Alzheimer's disease.
Lomoio S; López-González I; Aso E; Carmona M; Torrejón-Escribano B; Scherini E; Ferrer I
J Alzheimers Dis; 2012; 31(2):285-300. PubMed ID: 22561329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]